Clarivate Plc

AI-generated fair value estimate for this company.

Method: 10-year FCFE DCF: $280M normalized levered free cash flow base (haircut from $327.6M TTM reported FCF for working-capital timing); 2% annual FCF growth years 1-5, 1.5% years 6-10; 13% cost of equity reflecting ~$4.05B net debt and refinancing risk; 1.5% terminal growth; 639.66M diluted shares outstanding.

Reasoning: Clarivate is a capital-light, high-margin IP and scientific-analytics subscription business, so an equity free-cash-flow DCF is more appropriate than an EV/EBITDA multiple given its unusually high leverage (~4.3x net debt to FCF); the high discount rate and conservative growth reflect the elevated refinancing and organic-growth risk investors are pricing into the stock.